Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health insurers to cover preventive care services including those for reducing HIV risk and ...

Gilead Shares Rise After US Top Court Ruling on Preventive Coverage By Mariam Sunny and Mrinalika Roy (Reuters) -Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal ...

Gilead has blamed the low rate of respiratory syncytial virus infections last season for ending two midstage trials of obeldesivir.

Royalty Pharma announced a $2 billion funding arrangement with Revolution Medicines. Kymera Therapeutics shrugged off a setback with Sanofi by announcing a $750 million deal with Gilead Sciences.

This is the moment for Israel to move on from intense military operations to political statecraft.

Marketing GSK, Gilead, Novo Nordisk join other Big Pharmas in honoring 2025 LGBTQ+ Pride Month By Andrea Park Jun 26, 2025 3:31pm LGBTQ+ Diversity Novo Nordisk Novartis ...

Before Gilead’s rise, the world in The Handmaid’s Tale was already falling apart. Food shortage, political unrest, environmental disasters — it was all there, bubbling just under the surface.

Gilead Sciences and Kymera Therapeutics have entered into a partnership worth as much as $750m to develop a molecular glue degrader (MGD) programme with “broad oncology treatment potential”. The ...

A new fossil discovery technique reveals that squids originated and rapidly became abundant, diverse, and dominant in the oceans 100 million years ago, reshaping our understanding of ancient ...

Gilead Sciences partners with Kymera Therapeutics in a $750 million deal to develop molecular glue degraders for breast cancer treatment.

Kymera Therapeutics may have signed a $750 million deal with Gilead, but the Watertown biotech also suffered a setback in its partnership with Sanofi.